A Novel Competing-Risk Model Integrating Systemic Inflammation to Predict Acute-on-Chronic Liver Failure
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Aims: Absolute risk of acute-on-chronic liver failure (ACLF) can be overestimated when the hazards of competing events, such as liver transplantation (LT) or death without ACLF, are not incorporated. We developed and validated a novel competing-risk-based model integrating systemic inflammation to predict ACLF development. Methods: The derivation cohort comprised 1,146 patients with acute decompensation of cirrhosis from the prospective, multicenter Korean Acute-on-Chronic Liver Failure (KACLiF) cohort. External validation used a retrospective 1,104-patient cohort. The study followed the TRIPOD+AI reporting guidelines and applied a Fine-Gray subdistribution hazard model accounting for the competing risks of death or LT, with predictive performance evaluated using the C-index and time-dependent area under the receiver operating characteristic curve (AUROC). Results: The KACLiF-ACLF score integrated C-reactive protein, albumin, total bilirubin, international normalized ratio, and creatinine. In derivation, the competing-risk C-index (0.806 at 28 days; 0.791 at 90 days) significantly exceeded all eight comparators at 90 days, but not MELD or MELD-Na at 28 days. In external validation, it (0.892 and 0.889) significantly exceeded all comparators at both horizons. Time-dependent AUROCs at 28 days were 0.815 and 0.894, significantly exceeding all comparators at both horizons except MELD-Na at 28 days in derivation. Transported absolute risks were overpredicted, requiring recalibration. The model stratified patients into low-, intermediate-, and high-risk groups, correlating with cumulative ACLF incidence and transplant-free survival (P<0.001). Conclusions: The KACLiF-ACLF score discriminates ACLF development with high accuracy in external validation and supports risk stratification within a competing-risk framework. Recalibrated absolute risks require independent validation before clinical implementation.
Authors: Heechul Nam, Hee Yeon Kim, Young Kul Jung, Hyung Joon Yim, Tae Hyung Kim, Eileen L Yoon, Jung-Hee Kim, Sung-Eun Kim, Ki Tae Suk, Dong Joon Kim, Jeong-Ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Jung Gil Park, Won Kim, Do Seon Song, on behalf of the Korean Acute-on-Chronic Liver Failure (KACLiF) study group
Institutions: The Catholic University of Korea Uijeongbu St. Mary's Hospital, Catholic University of Korea, The Catholic University of Korea Bucheon St. Mary's Hospital, Korea University Ansan Hospital, Korea University Anam Hospital, Hanyang University Seoul Hospital, Hanyang University, Hallym University, Soonchunhyang University Hospital Bucheon, Yonsei University, Wonju Severance Christian Hospital, Yonsei University Mirae Campus, Soonchunhyang University, Yeungnam University College, Yeungnam University, Seoul National University, Seoul Metropolitan Government, SNUH SMG-SNU Boramae Medical Center, The Catholic University of Korea St. Vincent's Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $32
OpenAlex ID: W7234732067
